Master Data Changes: GTIN, GLN, SSCC, and Who Approves



Master Data Changes: GTIN, GLN, SSCC, and Who Approves

Published on 09/12/2025

Master Data Changes: GTIN, GLN, SSCC, and Who Approves

Introduction to Master Data Management in Serialization

The implementation of serialization within the pharmaceutical supply chain requires rigorous management of master data, which encompasses Global Trade Item Numbers (GTIN), Global Location Numbers (GLN), and Serial Shipping Container Codes (SSCC). These elements ensure product traceability and integrity throughout distribution, aligning with regulatory standards such as DSCSA compliance in the United States and the EU FMD requirements in Europe. This guide details the step-by-step processes involved in managing changes to master data, focusing on testing, approvals, exception handling, and compliance.

Understanding Key Components of Master Data Changes

Master data changes in serialization refer to modifications or updates involving GTINs, GLNs, and SSCCs, which are vital for adhering to serialization standards. The dynamic nature of pharmaceutical products necessitates a structured approach to manage these changes effectively. The following components should be considered:

  • Global Trade Item Number (GTIN): Used for identifying products and packages globally.
  • Global Location Number (GLN): Identifies parties involved in the supply chain, including manufacturers and distributors.
  • Serial Shipping Container Code (SSCC): A unique identifier for logistic units, which aids in tracking throughout the supply chain.

The Importance of Change Control in Serialization

Change control is a critical aspect of the serialization process, ensuring that any modifications made to master data are documented appropriately, reviewed, and approved. The principles of ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, and complete) must be adhered to throughout the process to maintain data integrity. Implementing a robust change control procedure can help mitigate risks associated with inaccurate or unauthorized changes.

Step 1: Identifying the Need for Master Data Changes

Before any updates can be made, it is crucial to identify the need for changes in master data. This may arise from:

  • Regulatory updates requiring changes to GTINs or GLNs.
  • Product rebranding or formulation adjustments necessitating new identifiers.
  • Updates in logistics practices leading to changes in SSCC.
  • Results from routine audits indicating discrepancies in existing data.

In this step, a thorough analysis must be conducted to ascertain the impact of the changes. This analysis should encompass potential repercussions on supply chain data integrity and compliance requirements.

Step 2: Drafting the Change Request

A formal change request must be drafted once the need for changes is identified. This document should encompass:

  • A detailed description of the current and proposed master data values.
  • The rationale behind the changes.
  • An assessment of the risks associated with not implementing the changes.
  • A proposed timeline for the implementation.

Authorship of this document typically falls on a designated team member or project manager responsible for serialization management, ensuring accuracy and completeness.

Step 3: Reviewing and Approving Change Requests

The review process ensures that the proposed changes are justified and aligned with regulatory requirements. A cross-functional team, including personnel from quality assurance, regulatory affairs, and clinical operations, should be involved. The review should address:

  • Compliance with regulatory frameworks such as EMA and MHRA standards.
  • Impact analysis on existing master data flows and system interfaces.
  • Evaluation of how the changes will affect reconciliation rules and overall aggregation hierarchy.

Post-review, the change request must be approved by a relevant authority, typically within the Quality Management System (QMS) frameworks, ensuring traceability and accountability.

Step 4: Implementing Master Data Changes

Upon receiving approval, the actual implementation of changes can commence. This step entails:

  • Updating master data systems to reflect new GTINs, GLNs, and SSCCs.
  • Ensuring that all internal and external stakeholders are notified of the changes.
  • Adjusting related documentation, such as packaging and labeling, in compliance with updated identifiers.

Communication with logistics partners is pivotal during this phase, as they must also integrate the updated identifiers into their tracking systems. This ensures seamless transition and compliance throughout the supply chain.

Step 5: Testing and Validation of Changes

The new master data must be thoroughly tested to confirm stability and functionality within existing systems. Validation activities should include:

  • Controlled testing of the updated data in a staging environment.
  • Verification against reconciliation rules to ensure aggregated data is accurate across hierarchical levels.
  • Data integrity checks to confirm adherence to the ALCOA+ principles.

Results from these tests must be documented and reviewed, establishing a clear audit trail that supports regulatory compliance. If issues arise during testing, exception handling procedures must be activated to address them promptly.

Step 6: Documentation and Audit Trail Review

Robust documentation practices are essential for maintaining compliance and ensuring traceability. Every stage of the change control process must be accompanied by appropriate records, including:

  • Change request forms.
  • Review and approval documentation.
  • Results of testing and validation procedures.

Regular audit trail reviews should be undertaken to ensure ongoing compliance with regulatory expectations and to identify any potential gaps in data integrity. Effective audit trails not only support compliance but also enable better decision-making and accountability within the organization.

Step 7: Training and Communication

Post-implementation, ongoing training and communication are essential for ensuring that all employees understand the changes made to master data management practices. Training sessions should encompass:

  • Updated processes for managing GTINs, GLNs, and SSCCs.
  • Understanding of reconciliation rules and exception handling.
  • Awareness of regulatory requirements and implications of serialization changes.

Support materials such as user manuals and FAQs can enhance understanding and compliance across the organization. Continual reinforcement of these processes ensures that employees remain engaged and informed.

Conclusion

In conclusion, managing master data changes in the pharmaceutical industry is a complex yet critical endeavor that involves multiple stakeholders and requires strict adherence to regulatory compliance. By following this step-by-step guide, pharmaceutical professionals can establish a framework for effectively managing GTIN, GLN, and SSCC changes that not only ensures compliance with bodies like the FDA, EMA, and MHRA but also fosters data integrity and efficient supply chain practices. The implementation of rigorous serialization change control procedures is paramount for safeguarding product authenticity and patient safety in the ever-evolving pharmaceutical landscape.